RELMADA THERAPEUTICS, INC.

RLMD · Nasdaq · SIC 2834: Pharmaceutical Preparations
236
SEC Filings

Business Summary

Business Overview Relmada Therapeutics, Inc. (Relmada, the Company, we or us) (a Nevada corporation), is a publicly traded, clinical-stage biotechnology company. We substantially redesigned our development programs following a comprehensive strategic review in late 2024 and early 2025. We concluded in our review that the most promising path to create shareholder value was to lever our extensive drug development expertise and clinical operations capabilities by acquiring new development candidate...

Next Earnings

Q2 FY2026 — expected 2026-09-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRLMDdiscussed_in_filing Cybersecurity
topic_mentionRLMDdiscussed_in_filing Trusted Computing
topic_mentionRLMDdiscussed_in_filing Blockchain & Crypto
topic_mentionRLMDdiscussed_in_filing Regulation
topic_mentionRLMDdiscussed_in_filing Healthcare & Bio
topic_mentionRLMDdiscussed_in_filing AI Compute
topic_mentionRLMDdiscussed_in_filing Sovereign & Government
topic_mentionRLMDdiscussed_in_filing Cybersecurity
topic_mentionRLMDdiscussed_in_filing Trusted Computing
topic_mentionRLMDdiscussed_in_filing Blockchain & Crypto
topic_mentionRLMDdiscussed_in_filing Regulation
topic_mentionRLMDdiscussed_in_filing Healthcare & Bio
topic_mentionRLMDdiscussed_in_filing AI Compute
topic_mentionRLMDdiscussed_in_filing Sovereign & Government
topic_mentionRLMDdiscussed_in_filing Cybersecurity
topic_mentionRLMDdiscussed_in_filing Trusted Computing
topic_mentionRLMDdiscussed_in_filing Blockchain & Crypto
topic_mentionRLMDdiscussed_in_filing Regulation
topic_mentionRLMDdiscussed_in_filing Healthcare & Bio
topic_mentionRLMDdiscussed_in_filing AI Compute

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001213900-26-031862EDGAR49K words
2025-03-272024-12-310001013762-25-003426EDGAR
2024-03-192023-12-310001213900-24-024013EDGAR
2023-03-232022-12-310001213900-23-022463EDGAR
2022-03-252021-12-310001213900-22-015012EDGAR
2021-03-242020-12-310001213900-21-017556EDGAR
2019-09-242019-06-300001213900-19-018787EDGAR
2018-09-282018-06-300001213900-18-013238EDGAR
2017-09-282017-06-300001213900-17-010097EDGAR
2016-09-092016-06-300001213900-16-016664EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001213900-25-109983EDGAR17K words
2025-08-072025-06-300001213900-25-073073EDGAR
2025-05-122025-03-310001213900-25-042025EDGAR
2024-11-072024-09-300001213900-24-095398EDGAR
2024-08-072024-06-300001213900-24-066111EDGAR
2024-05-082024-03-310001213900-24-040856EDGAR
2023-11-082023-09-300001213900-23-084737EDGAR
2023-08-082023-06-300001213900-23-064519EDGAR
2023-05-112023-03-310001213900-23-038533EDGAR
2022-11-102022-09-300001213900-22-071154EDGAR
2022-08-112022-06-300001213900-22-046934EDGAR
2022-05-052022-03-310001213900-22-024229EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-200001213900-26-032403EDGAR4K words
2026-03-090001213900-26-024918EDGAR
2025-12-150001213900-25-121461EDGAR
2025-11-130001213900-25-110088EDGAR
2025-11-050001213900-25-106398EDGAR
2025-11-040001213900-25-105593EDGAR
2025-09-170001213900-25-088360EDGAR
2025-09-160001213900-25-087926EDGAR
2025-09-100001213900-25-086389EDGAR
2025-09-020001213900-25-082910EDGAR

236 total filings indexed. 204 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001553643
TickerRLMD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 0442148baf19d9ce1e5a41c514b621dac66650b026f69b24d4539edf882348a8
parent: e0a877f9f3581a560b1142e6f9fb49d914d9a210679c296887e8c1116a9b55dc
content hash: a3a8fe4df0701b1b9bdd94950e3a8790bb21dcac5da2151572d09358ed985956
signed: 2026-04-13T04:47:12.782Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf